New gout drug ABP-671 shows promise in lowering uric acid
Disease control
Completed
This study tested a new drug called ABP-671 in 300 adults with gout. The goal was to see if it could safely lower uric acid levels in the blood. Participants received either ABP-671, a placebo (dummy pill), or the standard gout drug allopurinol. The main measure of success was th…
Phase: PHASE2, PHASE3 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated May 14, 2026 12:03 UTC